Insulin sensitivity and resistin expression in nitric oxide-deficient rats

Diabetologia

Volumn 49, Issue 12, 2006, Pages 3017-3026

  Juan, C C ^a,b   Chang, C L ^a   Chuang, T Y ^a   Huang, S W ^a,b   Kwok, C F ^b   Ho, L T ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Adipocyte; Insulin binding; Insulin sensitivity; Nitric oxide; Resistin

Indexed keywords

INSULIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; RESISTIN;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE FLUCTUATION; CELL ISOLATION; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; IN VITRO STUDY; IN VIVO STUDY; INSULIN BINDING; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; METABOLIC DISORDER; NONHUMAN; NORTHERN BLOTTING; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; SPECIES COMPARISON;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; INSULIN; MALE; NG-NITROARGININE METHYL ESTER; NITRIC ACID; RATS; RATS, SPRAGUE-DAWLEY; RESISTIN; RNA, MESSENGER;

EID: 33750919431     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0403-4     Document Type: Article

References (50)

1. Dominiczak AF, Bohr DF (1995) Nitric oxide and its putative role in hypertension. Hypertension 25:1202-1211
2. Ceravolo R, Maio R, Pujia A et al (2003) Pulse pressure and endothelial dysfunction in never-treated hypertensive patients. J Am Coll Cardiol 41:1753-1758
3. John S, Schmieder RE (2003) Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia. Curr Hypertens Rep 5:199-207
4. Kawashima S (2004) Malfunction of vascular control in lifestyle-related diseases: endothelial nitric oxide (NO) synthase/NO system in atherosclerosis. J Pharmacol Sci 96:411-419
5. Caballero AE (2004) Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes. Curr Diab Rep 4:237-246
6. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37:1595-1607
7. Young ME, Radda GK, Leighton B (1997) Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro. Biochem J 322:223-228
8. Tanaka T, Nakatani K, Morioka K et al (2003) Nitric oxide stimulates glucose transport through insulin-independent GLUT4 translocation in 3T3-L1 adipocytes. Eur J Endocrinol 149:61-67
9. ω-nitro-L-arginine methyl ester administration on glucose tolerance and skeletal muscle glucose transport in the rat. Nitric Oxide 3:312-320
10. Duplain H, Burcelin R, Sartori C et al (2001) Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 104:342-345
11. Shankar RR, Wu Y, Shen HQ, Zhu JS, Baron AD (2000) Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes 49:684-687
12. Kawano T, Nomura M, Nisikado A, Nakaya Y, Ito S (2003) Supplementation of L-arginine improves hypertension and lipid metabolism but not insulin resistance in diabetic rats. Life Sci 73:3017-3026
13. Kapur S, Bedard S, Marcotte B, Cote CH, Marette A (1997) Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes 46:1691-1700
14. Butler R, Morris AD, Struthers AD (1998) Systemic nitric oxide synthase inhibition increases insulin sensitivity in man. Clin Sci (Lond) 94:175-180
15. Spiegelman BM, Flier JS (1996) Adipogenesis and obesity: rounding out the big picture. Cell 87:377-389
16. Steppan CM, Bailey ST, Bhat S et al (2001) The hormone resistin links obesity to diabetes. Nature 409:307-312
17. Muse ED, Obici S, Bhanot S et al (2004) Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 114:232-239
18. Banerjee RR, Rangwala SM, Shapiro JS et al (2004) Regulation of fasted blood glucose by resistin. Science 303:1195-1198
19. Satoh H, Nguyen MT, Miles PD, Imamura T, Usui I, Olefsky JM (2004) Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J Clin Invest 114:224-231
20. Wang H, Chu WS, Hemphill C, Elbein SC (2002) Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. J Clin Endocrinol Metab 87:2520-2524
21. Juan CC, Shen YW, Chien Y, Lin YJ, Chang SF, Ho LT (2004) Insulin infusion induces endothelin-1-dependent hypertension in rats. Am J Physiol Endocrinol Metab 287:E948-E954
22. Legro RS, Driscoll D, Strauss JF III, Fox J, Dunaif A (1998) Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A 95:14956-14960
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
24. Satoh H, Nguyen MT, Trujillo M et al (2005) Adenovirus-mediated adiponectin expression augments skeletal muscle insulin sensitivity in male Wistar rats. Diabetes 54:1304-1313
25. Juan CC, Chien Y, Wu LY et al (2005) Angiotensin II enhances insulin sensitivity in vitro and in vivo. Endocrinology 146:2246-2254
26. Rodbell M (1964) Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239:375-380
27. Huang SW, Seow KM, Ho LT et al (2005) Resistin mRNA levels are downregulated by estrogen in vivo and in vitro. FEBS Lett 579:449-454
28. Rosen ED, Sarraf P, Troy AE et al (1999) PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4:611-617
29. Kim KH, Lee K, Moon YS, Sul HS (2001) A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 276:11252-11256
30. McGrowder D, Ragoobirsingh D, Dasgupta T (2001) Effects of S-nitroso-N-acetyl-penicillamine administration on glucose tolerance and plasma levels of insulin and glucagon in the dog. Nitric Oxide 5:402-412
31. 3H]-deoxyglucose muscle uptake. Am J Hypertens 10:683-686
32. Pueyo ME, Gonzalez W, Pussard E, Arnal JF (1994) Insulin secretion in rats with chronic nitric oxide synthase blockade. Diabetologia 37:879-884
33. Kaneko Y, Ishikawa T, Amano S, Nakayama K (2003) Dual effect of nitric oxide on cytosolic Ca2+ concentration and insulin secretion in rat pancreatic beta-cells. Am J Physiol Cell Physiol 284:C1215-C1222
34. Ragoobirsingh D, McGrowder D, Dasgupta T, Brown P (2004) The effect of nitric oxide on glucose metabolism. Mol Cell Biochem 263:29-34
35. Bredt DS, Hwang PM, Snyder SH (1990) Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347:768-770
36. Moncada S, Radomski MW, Palmer RM (1988) Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 37:2495-2501
37. Nathan CF, Hibbs JB Jr (1991) Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 3:65-70
38. Ohtoshi K, Yamasaki Y, Gorogawa S et al (2002) Association of (-)786T-C mutation of endothelial nitric oxide synthase gene with insulin resistance. Diabetologia 45:1594-1601
39. Monti LD, Barlassina C, Citterio L et al (2003) Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes 52:1270-1275
40. Yoshimura T, Hisatomi A, Kajihara S et al (2003) The relationship between insulin resistance and polymorphisms of the endothelial nitric oxide synthase gene in patients with coronary artery disease. J Atheroscler Thromb 10:43-47
41. Cook S, Hugli O, Egli M et al (2004) Partial gene deletion of endothelial nitric oxide synthase predisposes to exaggerated high-fat diet-induced insulin resistance and arterial hypertension. Diabetes 53:2067-2072
42. Sugita H, Kaneki M, Tokunaga E et al (2002) Inducible nitric oxide synthase plays a role in LPS-induced hyperglycaemia and insulin resistance. Am J Physiol Endocrinol Metab 282:E386-E394
43. Perreault M, Marette A (2001) Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med 7:1138-1143
44. Choi JW, Pai SH, Kim SK, Ito M, Park CS, Cha YN (2001) Increases in nitric oxide concentrations correlate strongly with body fat in obese humans. Clin Chem 47:1106-1109
45. Ribiere C, Jaubert AM, Gaudiot N et al (1996) White adipose tissue nitric oxide synthase: a potential source for NO production. Biochem Biophys Res Commun 222:706-712
46. Engeli S, Janke J, Gorzelniak K et al (2004) Regulation of the nitric oxide system in human adipose tissue. J Lipid Res 45:1640-1648
47. Yan H, Aziz E, Shillabeer G et al (2002) Nitric oxide promotes differentiation of rat white preadipocytes in culture. J Lipid Res 43:2123-2129
48. Lu SC, Shieh WY, Chen CY, Hsu SC, Chen HL (2002) Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett 530:158-162
49. Merial C, Bouloumie A, Trocheris V, Lafontan M, Galitzky J (2000) Nitric oxide-dependent downregulation of adipocyte UCP-2 expression by tumor necrosis factor-alpha. Am J Physiol Cell Physiol 279:C1100-C1106
50. Lin SY, Sheu WH, Chen WY, Lee FY, Huang CJ (2005) Stimulated resistin expression in white adipose of rats with bile duct ligation-induced liver cirrhosis: relationship to cirrhotic hyperinsulinemia and increased tumor necrosis factor-alpha. Mol Cell Endocrinol 232:1-8